NYSE:GS

Goldman Sachs (GS)

1,055.03
-10.19 (0.96%)
as of Jul 20, 2026, 8:00:00 pm Market Open.
229 watching
0
Investor Insights
star iconJul 20, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Goldman Sachs (GS) has experienced spectacular earnings, reflected in a notable price jump and a new all-time high. Analysts are bullish, anticipating a booming IPO market that could further benefit the firm, especially as they solidify their position in investment banking and advisory services. The company has raised its dividend significantly, showcasing its commitment to returning capital to shareholders. While experts recognize potential challenges, particularly due to competition and market conditions, many still regard GS as a top choice within the financial sector, especially in light of stronger merger and acquisition activities expected in the near future. The stock is viewed favorably against larger market trends and is expected to yield considerable returns in the coming years, fueling optimism about its growth trajectory.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
JPM, JPM
DON'T BUY

It remains too dependent on proprietary trading and investment banking.

BUY

He added to it a few weeks ago. Their well-positioned to benefit from the capital cycle returning (more IPOs). They have a deep bench.

DON'T BUY

Capital market activity may return next year (IPOs) to benefit GS. Last quarter, their revenues have been down 8%. He prefers Morgan Stanley for being a pure play, even though financials are not a great place being late-cycle.

BUY

Very low price to tangible book, and a really cheap 10x earnings. Stumbled in the consumer area, cleaning that up. Tremendous free cashflow, buying back shares, dividend increases will be ongoing. 

BUY

He added more shares. It's cheap here. The CEO is performing well, and he expects capital markets to come back. If markets continue to improve, the IPO market will return, which will benefit GS, likely in late 2024. $320 seems to be the bottom, a place to add. The negative press is behind them.

PAST TOP PICK
(A Top Pick May 11/22, Up 22%)

Trading at cheapest level since financial crisis (1x book value).
Consumer finance business weighing down company (expects problem to pass).
Ongoing dividend increases. 
Best in class investment bank.
Current share price presenting excellent buying opportunity.

PARTIAL BUY

They report next week. Are concerns over how the CEO is running the company. Their retail business was clearly a failure and they want to exit this business. JPM reported solid numbers today. Some of the bad news is behind GS, so there is some upside ahead.

BUY

It reported yesterday. The street misinterpreted that report and shares sank in pre-market trading--business dropped 17% YOY, but that number was compared to the single-greatest quarter that that division had ever had. Later, the stock erased those heavy losses.

BUY

Trading at 1x book. Pays over 3% dividend.

BUY ON WEAKNESS

The consumer segment has been a mess, but there's upside in asset management that they stressed on investor day. Down only 6.5% which is a win.

DON'T BUY

He used to work here 40 years ago. The bank has totally changed. GS is embracing everyday consumer banking; it paid $2.23 billion for Green Sky (which specializes in consumer loan originations) at the top of the fintech craze. He doesn't like this shift.; in his days he was pushed to bring in super-rich clients. Instead, GS should sell its consumer division entirely.

DON'T BUY

He used to work here 40 years ago. The bank has totally changed. GS is embracing everyday consumer banking; it paid $2.23 billion for Green Sky (which specializes in consumer loan originations) at the top of the fintech craze. He doesn't like this shift.; in his days he was pushed to bring in super-rich clients. Instead, GS should sell its consumer division entirely.

BUY

They have an investor day Tuesday. Likes it for its 10x earnings, as low as it will get, because the capital markets business is dead.

DON'T BUY

They bought off more than they can chew, and this year will see retrenchment by cutting expenses. Shares will be rangebound for a while.  Comare their asset management business to Morgan Stanley's, which is performing far better. GS needs to fix this.

HOLD

They'll likely change their CEO, but that signifies nothing. Their last quarter wasn't good and they admitted they made mistakes, but he'd remain long on GS.

Showing 76 to 90 of 401 entries